{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-074005","form_type":"8-K","ticker":"SENS","cik":"0001616543","company_name":"Senseonics Holdings, Inc.","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.265867+00:00","generated_at":"2026-06-01T02:51:31.086756+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Senseonics sees H1 2024 net rev $10M, +21% YoY; FY 2024 guidance $22-24M","bullets":["Reaffirmed H1 2024 global net revenue $10M, 21% growth over H1 2023.","US new patient starts H1 2024 >200% higher than H1 2023.","FDA 510(k) for 365-day Eversense on track for Q4 2024 launch.","Mercy Health collaboration initiated; first insertions targeted Q3 2024.","FY 2024 revenue guidance $22-24M; cash utilization ~$70M."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-074005","json":"https://secwatch.observer/filing/0001104659-24-074005.json","markdown":"https://secwatch.observer/filing/0001104659-24-074005.md","text":"https://secwatch.observer/filing/0001104659-24-074005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924074005/0001104659-24-074005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924074005/tm2417819d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:51:31.086756+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}